MS in the Media - 3 April 2020
28 March - 3 April 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Support for carers during the current situation
Informal and family carers need more support as they try to look after people while dealing with reduced help from health and care services warn the carer support charities. The story includes the experience of a couple affected by MS
Source: Daily Express
MS Trust link: A family talks about caring (written before the current situation)
Ozanimod approved for RRMS
Ozanimod (Zeposia), a drug for relapsing remitting MS that works in a similar way to Gilenya, has been approved for licensing by the European Medicines Agency (EMA).
Source: MS News Today
MS Trust link: Ozanimod (Zeposia)
"Starting a podcast in lockdown helped us take ownership of the situation"
23 Apr 2021 - 00:00
Comedian, Jeanette and Poet, Lytisha, talk about how creating their own podcast, about life with MS, led to lots of laughs, feelings of empowerment and a sense of community during lockdown.
Twelve year old Lacey hasn't been able to hug her dad for a year
23 Apr 2021 - 00:00
Before lockdown Lacey visited her dad every other weekend, but Covid restrictions have meant she’s not been able to visit her dad in his care home and give him a hug since March 2020.
'This is my normal now. I rather like it.' Living with PPMS in lockdown
23 Apr 2021 - 00:00
John Peters tells us how his working life changed during lockdown and how he’ll be quite happy not to go back to ‘normal’.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
